CD36 and CD4+/CD56+ hematodermic neoplasm: BPDCN is characterized by high levels of CD123 and weak expression of CD45, while also being positive for CD4, CD36, CD56, as well as absence of lineage-associated antigens; this is considered a unique phenotype virtually pathognomonic of BPDCN [6].